Statistics for Eupraxia Pharmaceuticals Inc. (id:13714 EPRX)

Valuation metrics

Market cap

166.91M

Enterprise value

191.16M

Trailing P/E (ttm)

-4.04

Forward P/E

-7.08

PEG ratio

-7.08

Price/Sales (ttm)

Price/Book (mrq)

56.79

Enterprise Value/Revenue

Enterprise Value/EBITDA

-4.31

Overview

Shares outstanding

35.62M

Float

28.67M

Shares short

15.90K

% Held by insiders

0.11%

% Held by institutions

0.13%

Average volume (10 days)

27.99K

Average volume (90 days)

Price summary

52-Week low

3.07

52-Week high

7.64

52-Week change

-26.64%

Beta

1.23

50-Day moving average

3.68

200-Day moving average

4.11

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-98.68%

Return on equity

-314.41%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-44,338,217.00

Net income to common (ttm)

-37,687,340.00

Diluted EPS (ttm)

-1.31

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

32.55M

Total cash per share (mrq)

0.66

Total debt (mrq)

6.50M

Total Debt/Equity (mrq)

34.94

Current ratio (mrq)

211.40%

Book value per share (mrq)

0.08

Cash flow

Cash flow statement

-35,842,379.00

Levered free cash flow (LFCF)

-20,401,282.00